title: Application of colon interposition among the esophageal cancer patients with partial gastrectomy.
abstract: BACKGROUND
  Esophageal reconstruction with colon interposition is an alternative solution for the esophageal cancer patients who have partial gastrectomy. The aim of this study was to investigate the therapeutic effects of colon interposition among the esophageal carcinoma patients with partial gastrectomy.
  
  
  METHODS
  Under institutional review board approval, 32 esophageal carcinoma patients with a history of partial gastrectomy were included in this study. All the patients had been diagnosed and confirmed squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma by histopathological examination. Surgical approaches, complications and therapeutic results were analyzed in the current study.
  
  
  RESULTS
  Thirty-two esophageal carcinoma patients (29 men, 3 women, median age 63.2 years) were included in this study. Isoperistaltic colon interposition was carried out on 14 patients; their 1-year and 2-year survival rate was 92.9% and 78.6%, respectively. Antiperistaltic colon interposition was carried out on 18 patients; their 1-year and 2-year survival rate was 88.9% and 77.8%, respectively. In which, cervical anastomotic leakage was observed on six patients.
  
  
  CONCLUSIONS
  Colon interposition is an ideal surgical approach for the esophageal carcinoma patients who had partial gastrectomy. Isoperistaltic colon interposition is preferred, but antiperistaltic colon interposition has the advantage that a longer colon can be used.
authors.affiliation: Department of Thoracic Surgery, The First Hospital Affiliated to Huzhou University School of Medicine, Huzhou, Zhejiang, China.
authors.forename: Qiuqiang
authors.initials: Q
authors.lastname: Chen
authors.affiliation: Department of Thoracic Surgery, Zhejiang Provincial Cancer Hospital, Hangzhou, Zhejiang, China.
authors.forename: Weimin
authors.initials: W
authors.lastname: Mao
authors.affiliation: Department of Thoracic Surgery, The First Hospital Affiliated to Huzhou University School of Medicine, Huzhou, Zhejiang, China.
authors.forename: Huanming
authors.initials: H
authors.lastname: Yu
authors.affiliation: Department of Thoracic Surgery, The First Hospital Affiliated to Huzhou University School of Medicine, Huzhou, Zhejiang, China.
authors.forename: Yixian
authors.initials: Y
authors.lastname: Liang
authors.affiliation: Department of Thoracic Surgery, The First Hospital Affiliated to Huzhou University School of Medicine, Huzhou, Zhejiang, China.
authors.forename: Jiane
authors.initials: J
authors.lastname: Wang
authors.affiliation: Department of Thoracic Surgery, Zhejiang Hospital, Hangzhou, Zhejiang, China.
authors.forename: Guoping
authors.initials: G
authors.lastname: Chen
mesh_terms: D000328:Adult; D000368:Aged; D003106:Colon / Q000601:surgery*; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011183:Postoperative Complications; D019651:Plastic Surgery Procedures / Q000009:adverse effects / Q000379:methods*; D016019:Survival Analysis; D016896:Treatment Outcome